AIM: To study the efficacy of the enhanced recovery after surgery (ERAS) program in laparoscopic radical gastrectomy for @entity189 . METHODS: From June 2010 to December 2012, 61 @entity356 @entity1 who underwent laparoscopic-assisted radical gastrectomy with D2 lymphadenectomy at First Hospital of Jilin University were enrolled in this randomized controlled trial. (Clinical Trials.gov, registration ID: NCT01955096). The subjects were divided into the ERAS program group and the conventional control group. The clinical characteristics, recovery variables, and complications of @entity1 were analyzed. RESULTS: The time to first ambulation, oral food intake, and time to defecation were significantly shorter in the ERAS group (n = 30), compared to the conventional group (n = 31; P = 0.04, 0.003, and 0.01, respectively). The postoperative hospital stay was less in the ERAS group (6.8    1.1 d) compared to the conventional group (7.7    1.1 d) (P = 0.002). There was no significant difference in postoperative complications between the ERAS (1/30) and conventional care groups (2/31) (P = 1.00). There were no readmissions or mortality during the 30-d follow-up period. CONCLUSION: The ERAS program is associated with a shorter hospital stay in @entity356 @entity1 undergoing laparoscopic radical gastrectomy. The ERAS protocol is useful in the treatment of @entity356 .

Enhanced recovery after surgery with laparoscopic radical gastrectomy for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer'] @entity189 :: ('MESH:D002277', 'Disease') :: ['stomach carcinomas']
@entity189 :: (MESH:D002277,Disease) :: ['stomach carcinomas']
